| 000 | 01810 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516095434.0 | ||
| 264 | 0 | _c20130522 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1478-6362 | ||
| 024 | 7 |
_a10.1186/ar3879 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaoussis, Dimitrios | |
| 245 | 0 | 0 |
_aB-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin. _h[electronic resource] |
| 260 |
_bArthritis research & therapy _cJun 2012 |
||
| 300 |
_aR145 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFibrosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aLymphocyte Depletion _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptor, Platelet-Derived Growth Factor alpha _xbiosynthesis |
| 650 | 0 | 4 |
_aReceptor, Platelet-Derived Growth Factor beta _xbiosynthesis |
| 650 | 0 | 4 |
_aReceptors, Platelet-Derived Growth Factor _xmetabolism |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aScleroderma, Diffuse _xdrug therapy |
| 650 | 0 | 4 |
_aSkin _xmetabolism |
| 700 | 1 | _aTsamandas, Athanassios C | |
| 700 | 1 | _aLiossis, Stamatis-Nick C | |
| 700 | 1 | _aAntonopoulos, Ioannis | |
| 700 | 1 | _aKaratza, Elli | |
| 700 | 1 | _aYiannopoulos, Georgios | |
| 700 | 1 | _aAndonopoulos, Andrew P | |
| 773 | 0 |
_tArthritis research & therapy _gvol. 14 _gno. 3 _gp. R145 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/ar3879 _zAvailable from publisher's website |
| 999 |
_c21864163 _d21864163 |
||